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Abstract
 
Unmethylated CpG motifs present in bacterial DNA stimulate a strong innate immune re-
sponse. There is evidence that DNA-dependent protein kinase (DNA-PK) mediates CpG sig-
naling. Specifically, wortmannin (an inhibitor of phosphatidylinositol 3 kinase 
 
[
 
PI3]-kinases in-
cluding DNA-PK) interferes with CpG-dependent cell activation, and DNA-PK knockout
(KO) mice fail to respond to CpG stimulation. Current studies establish that wortmannin actu-
ally inhibits the uptake and colocalization of CpG DNA with toll-like receptor (TLR)-9 in en-
docytic vesicles, thereby preventing CpG-induced activation of the NF-
 
 
 
B signaling cascade.
We find that DNA-PK is not involved in this process, since three strains of DNA-PK KO mice
responded normally to CpG DNA. These results support a model in which CpG signaling is
mediated through TLR-9 but not DNA-PK, and suggest that wortmannin-sensitive member(s)
of the PI3-kinase family play a critical role in shuttling CpG DNA to TLR-9.
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Introduction
 
Toll-like receptors (TLRs) mediate host recognition of
“pathogen-associated molecular patterns” expressed by in-
fectious microorganisms (1). Engagement of TLR triggers
an innate immune response that promotes the elimination
of foreign pathogens and supports the development of
adaptive immunity (2). For example, “CpG motifs” present
at high frequency in bacterial, but not mammalian DNA,
interact with TLR-9, stimulating an immune response
characterized by the production of cytokines, chemokines,
and Ig by B lymphocytes, NK cells, macrophages, and den-
dritic cells (DCs; references 3–6).
Previous studies established that CpG DNA interacts
with TLR-9 in endosomal vesicles, triggering a signaling
cascade involving NF-
 
 
 
B–dependent pathways (7–9). Inde-
pendently, Chu et al. recently reported that the catalytic
subunit of DNA-dependent protein kinase (DNA-PKcs)
has a central role in CpG-mediated immune activation (10).
Their findings imply that CpG motifs must interact with
two independent receptor molecules (TLR-9 and DNA-
PKcs) before eliciting an innate immune response (11).
DNA-PK consists of three subunits (DNA-PKcs, Ku70,
and Ku80) that play a critical role in DNA repair and 
 
V(D)J
 
recombination (19–21). Other members of the phosphati-
dylinositol 3-kinase (PI3)-kinase family contribute to the
phosphorylation of membrane inositol lipids involved in
signal transduction and membrane transport (12, 13), facili-
tate the uptake and processing of foreign molecules, and
contribute to phagosome formation and maturation (14–
17). Wortmannin inhibits these events by blocking the
conserved ATP-binding site present in the catalytic domain
of the PI3-kinase family (18).
This work examines the mechanism by which wort-
mannin inhibits CpG-induced cellular activation and reex-
amines the involvement of DNA-PK in this process. Re-
sults indicate that wortmannin inhibits the uptake and/or
entry of CpG DNA into TLR-9-containing endocytic ves-
icles. In contrast to the report by Chu et al. (10), DNA-PK
was not involved in this process, since knockout (KO)
mice lacking each of the three functional subunits of
DNA-PK responded normally to CpG DNA. These find-
ings support a model in which one or more members of
the wortmannin-sensitive PI3-kinase family facilitate the
interaction of CpG DNA with TLR-9 in endocytic vesi-
cles, thereby triggering immune activation.
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Materials and Methods
 
Mice.
 
Female C57BL/6 mice (6–10-wk old) were obtained
from The Jackson Laboratory while DNA-PKcs
 
 
 
/
 
  
 
and Ku70
 
 
 
/
 
 
 
were obtained from Frederick Alt (Harvard Medical School, Bos-
ton, MA; references 19 and 20). Ku80
 
 
 
/
 
 
 
 mice were generated as
described previously (21). All studies were approved by the
CBER Animal Care and Use Committee.
 
Reagents.
 
Genomic DNA from 
 
E. coli
 
 and calf thymus, LPS,
and wortmannin were obtained from Sigma-Aldrich. Genomic
DNA was repurified by treatment with Triton-X114 to remove
LPS as described previously (22). Single-stranded DNA was pre-
pared by heat denaturing double-stranded DNA at 95
 
 
 
C for 5
min followed by immediate cooling on ice. Phosphorothioate,
Cy3-, and FITC-labeled oligodeoxynucleotides (ODNs) were
synthesized at the CBER core facility. The sequence of the
ODNs used in this work are: CpG ODN
 
1555
 
; GCTAGACGT-
TAGCGT, CpG ODN
 
1466
 
; TCAACGTTGA, human CpG
ODN
 
K3
 
; ATCGACTCTCGAGCGTTCTC, control ODN
 
1612
 
;
GCTAGATGTTAGCGT, control ODN
 
1471
 
; TCAAGCT-
TGA, and human control ODN
 
K10
 
; ATGCACTCTGCAG-
GCTTCTC (9, 23). Less than 0.01 U/
 
 
 
g of endotoxin was
present in any DNA used in this work, as determined by Limulus
amebocyte lysate (LAL) assay (Bio-Whittaker).
 
Cell Transfection and Luciferase Assay.
 
HEK-293 (5 
 
 
 
 10
 
4
 
)
cells (American Type Culture Collection) were transfected with
0.8 
 
 
 
g of vector plasmid (pCIneo; Promega), pCIneo-hTLR9,
or pCIneo-hTLR4 (9) plus 0.1 
 
 
 
g of p5xNF-
 
 
 
B-luc (Stratagene)
and 0.1 
 
 
 
g of pSV-
 
 
 
-galactosidase (Promega) and incubated for
24 h at 37
 
 
 
C. The cells were then stimulated with ODNs or LPS
for 24 h. Luciferase assays were performed according to the man-
ufacturer’s instructions (Promega). 
 
 
 
-galactosidase activity was
used to normalize the values.
 
Flow Cytometric Analysis of Cell Surface Molecule Expression.
 
In brief,
ODN-stimulated cells were washed with PBS, fixed with 4%
paraformaldehyde for 5 min at 37
 
 
 
C, and stained with FITC- or
PE-labeled Abs in the presence of anti-CD16 Ab for 30 min at
room temperature (22). Stained cells were washed, resuspended
in PBS/0.1% BSA plus azide, and analyzed by FACSort™ (BD
Biosciences). Abs specific for the following molecules were ob-
tained from BD PharMingen: CD11c; CD40; CD80; and CD86.
 
Cytokine-specific ELISA.
 
Immulon 2 microtiter plates (96-
well) were coated with anti–IL-12 (BD PharMingen) in PBS for
4 h. After the plates were blocked and washed, supernatants from
stimulated cells were added for 2 h at room temperature. The
plates were then washed and treated with biotinylated anticyto-
kine Ab followed by phosphatase-streptavidin (BD PharMingen)
as described previously (22). A standard curve generated using re-
combinant IL-12 was used to determine cytokine concentration.
 
CpG ODN Internalization.
 
Cells were incubated with 1–3
 
 
 
M FITC-labeled ODN plus 1 
 
 
 
M wortmannin at 37
 
 
 
C. Cells
were washed after 1 h, and surface-bound FITC was quenched
by trypan blue (1:4 dilution; Sigma-Aldrich). Internalized FITC
was quantified by FACSort™ (BD Biosciences) as described pre-
viously (24).
 
Confocal Microscopy.
 
HEK-293 cells that had been stably
transfected with human TLR-9 fused with HA (9) were incu-
bated with Cy3-labeled ODN for 10–120 min at 37
 
 
 
C. Cells
were washed, fixed, permeabilized, and stained with FITC–anti-
HA Ab (clone 3F10; Roche Laboratories). The subcellular local-
ization of Cy3 and FITC signals was determined by confocal mi-
croscopy (LSM5 PASCAL; Carl Zeiss).
 
Results
 
CpG DNA–induced Immune Activation Is Independent of
DNA-PK.
 
It was previously reported that DNA-PK plays
a critical role in mediating CpG DNA–dependent immune
activation (10). To confirm that finding, we examined the
response of three different strains of KO mice, each lacking
a different functional subunit of DNA-PK (DNA-PKcs,
Ku70, and Ku80) to various CpG motifs. These animals
had no mature T or B cells, as expected for the KO pheno-
type (19–21 and unpublished data). PCR analyses con-
firmed that the relevant DNA-PK genes were disrupted in
these animals (unpublished data). When spleen cells from
the KO mice were stimulated with bacterial DNA or CpG
ODNs (both phosphodiester and phosphorothioate), their
IL-12, IL-6, and IFN-
 
 
 
 responses did not differ signifi-
cantly from wild-type mice (Fig. 1 and unpublished data).
Similarly, bone marrow–derived DCs (BMDCs) from these
mice underwent normal cellular maturation (characterized
Figure 1. CpG DNA–induced cytokine produc-
tion and BMDC maturation are independent of
DNA-PK. Spleen cells (2.5   106 cells/ml) or
BMDCs (5   105 cells/ml) from DNA-PKcs / ,
Ku70 / , Ku80  / , and wild-type mice were in-
cubated with 50  g/ml of calf thymus (CT) or E.
coli (EC) DNA, 1  M for phosphorothioate
ODNs, or 10  M of phosphodiester ODNs (PO)
for 48 h. IL-12 levels in culture supernatants were
measured by ELISA, while the percentage of ma-
ture DCs (expressing high levels of both CD11c
and CD40) was evaluated by FACS®. Data repre-
sent the average   SD of the samples from three
mice per group. 
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by the upregulation of CD40, CD80, and CD86) when
stimulated with CpG DNA (Fig. 1 and unpublished data).
Thus, in contrast to the results reported by Chu et al. we
found no deficit in the immune response of DNA-PK KO
mice to CpG motifs.
 
CpG DNA–induced Immune Activation Is Wortmannin De-
pendent.
 
Chu’s finding that wortmannin could inhibit
CpG DNA–induced immune activation was then exam-
ined. BMDCs were isolated from wild-type and DNA-
PKcs KO mice and stimulated with CpG ODN, bacterial
DNA, LPS, or double-stranded RNA. Wortmannin signif-
icantly inhibited CpG-induced cytokine production and
BMDC maturation by cells isolated from both wild-type
and KO mice (Fig. 2 and unpublished data). In contrast,
wortmannin had no effect on the immune activation in-
duced by LPS or double-stranded RNA (Fig. 2 and unpub-
lished data). These findings confirm that DNA-PK was not
involved in CpG-induced immune activation, and suggest
some other wortmannin-sensitive molecule (presumably a
different member of the wortmannin-sensitive PI3-kinase
family) plays a crucial role in mediating CpG-dependent
immune activation.
 
Effect of Wortmannin on CpG ODN Uptake.
 
The mech-
anism by which wortmannin inhibited CpG-dependent
immune activation was then examined. The interaction of
CpG DNA with TLR-9 triggers a signaling cascade in-
volving the rapid upregulation of NF-
 
 
 
B and the subse-
quent production of immunostimulatory cytokines and
chemokines (9, 23, 25). To monitor this activity, HEK-293
cells were transiently transfected in vitro with a TLR-9–
encoding plasmid (pCIneo-TLR-9) plus a NF-
 
 
 
B–depen-
dent luciferase reporter construct (p5xNF-
 
 
 
B-luc). Consis-
tent with previous findings, transfected cells stimulated
with CpG (but not control) ODNs increased luciferase ac-
tivity by more than ninefold (
 
P
 
   
 
0.01, Fig. 3 and refer-
 
ence 9). Wortmannin reduced this NF-
 
 
 
B–mediated in-
crease in luciferase expression in a dose-dependent manner
(
 
P 
 
 
 
 0.01, Fig. 3). This effect of wortmannin was CpG
specific, since HEK-293 cells cotransfected with the lu-
ciferase reporter plus a TLR-4–encoding plasmid (which
confers responsiveness to LPS) responded normally to LPS
stimulation in the presence of wortmannin (Fig. 3). These
findings are consistent with a wortmannin-sensitive PI3-
kinase contributing to the signaling process by which CpG
DNA activates NF-
 
 
 
B.
To further clarify the nature of this contribution, the up-
take and localization of CpG DNA was monitored by con-
focal microscopy. HEK-293 cells were stably transfected
with an HA-tagged TLR-9 construct, and then incubated
with Cy-3–labeled CpG ODN (red) and then stained with
anti-HA Ab (green). As seen in Fig. 4, CpG ODNs readily
entered transfected cells and colocalized in endocytic vesi-
cles with HA-tagged TLR-9. This interaction triggered the
activation of NF-
 
 
 
B and the production of immunostimu-
latory cytokines such as IL-8 (Fig. 3 and unpublished data).
However, when transfected cells were treated with wort-
mannin, both the size and number of endocytic vesicles
containing CpG ODNs plus TLR-9 decreases significantly,
as did NF-
 
 
 
B activation (Figs. 3 and 4). These findings
suggest that wortmannin interferes with the endosomal up-
take and/or colocalization of CpG ODNs with TLR-9 in
target cells.
To confirm this finding in cells that respond physiologi-
cally to CpG ODNs, the effect of wortmannin on the in-
ternalization of CpG ODNs and subsequent production of
IL-12 by BMDCs was examined. As seen in Fig. 5, wort-
mannin reduced the internalization of CpG ODNs by 90%
and the IL-12 response elicited by CpG ODNs by 85% (
 
P 
 
 
 
0.01) when compared with baseline. Similar results were
obtained using BMDCs from DNA-PK KO mice, estab-
lishing that wortmannin inhibits ODN internalization in a
Figure 2. Wortmannin inhibits IL-12 production by CpG DNA in
both wild-type and DNA-PKcs KO mice. The effect of wortmannin on
the production of IL-12 by BMDCs from both wild-type and DNA-
PKcs /  mice was evaluated as described in the legend to Fig. 1. Addi-
tional controls include double-stranded RNA (Poly IC, 50  g/ml) and
LPS (1  g/ml). Data represent the average   SD of three mice per
group. *P   0.01.
Figure 3. Wortmannin selectively inhibits CpG-induced NF- B acti-
vation. HEK 293 (5   104) cells were transfected with plasmids encoding
hTLR-9 or hTLR-4 plus p5xNF- B-luciferase. Cells were stimulated
the next day with 1  M of CpG (K3), control (K10) ODN, or 1  g/ml
of LPS in the presence or absence of wortmannin (WT). The increase in
luciferase activity at 24 h is shown. Results represent the average   SD of
triplicate cultures in experiments that were repeated three times. *P  
0.05, **P   0.01. 
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DNA-PK–independent manner (unpublished data). Taken
together, these data strongly suggest that wortmannin-sen-
sitive PI3-kinase(s) plays a critical role in the uptake and/or
localization of CpG ODNs with TLR-9.
 
Discussion
 
CpG motifs in bacterial DNA act as pathogen-associated
molecular patterns, interacting with TLR-9 to induce a
robust innate immune response (7–9). Previous studies es-
tablished that CpG DNA and TLR-9 colocalize in en-
docytic vesicles and that cellular activation is associated
with an increase in the size and number of these vesicles
(9). The process involved in the uptake, transport, and
colocalization of CpG DNA with TLR-9 have not been
established. Current results indicate that the internalization
of CpG ODNs is wortmannin sensitive, suggesting that
one or more members of the PI3-kinase family contribute
to this process.
Contrary to the conclusions in a previous report (10), we
find that CpG-mediated immune activation is a DNA-PK–
independent process. Supporting this conclusion is evi-
dence that cells from DNA-PK KO mice (lacking func-
tional DNA-PKcs, Ku70, or Ku80) internalize and respond
normally to CpG DNA. PCR analyses confirmed that the
relevant DNA-PK genes were disrupted in these KO mice.
In addition, phenotypic studies established that the ex-
pected abnormalities in T and B cell maturation/function
were present in these animals. Results shown in Figs. 1 and
2 are inconsistent with those of Chu et al. (10), who re-
ported that a different strain of DNA-PKcs KO mouse
failed to produce cytokine when stimulated by CpG DNA.
Unfortunately, that strain of DNA-PKcs KO mouse was
unavailable, preventing our performing a comparative
study of potential epigenetic differences. However, results
Figure 4. Wortmannin reduces the size and number of
vesicles containing CpG ODN plus TLR-9. HEK-293
cells were transfected HA-tagged TLR-9, and cultured
with 1  M of wortmannin plus Cy3 (red) labeled CpG
ODN (K3) for 2 h. Cells were then fixed, stained with
FITC-labeled anti-HA Ab (green), and analyzed by confo-
cal microscopy. The top panel shows the 3-dimensional
stacked pictures of 15 sections with 0.8- m thickness and
the bottom panel shows the representative section of the
cells treated with CpG ODNs alone. Each panel is repre-
sentative of multiple samples from repeat experiments.
Figure 5. CpG ODN internalization and subsequent activation of
BMDCs is inhibited by wortmannin. (A) 106 BMDC/ml were incubated
with FITC-labeled CpG ODN1555 plus 1  M of wortmannin. 60 min
later cells were washed on ice and the signal from surface-bound FITC
quenched using trypan blue. Internalized FITC was detected by FACS®.
Data represent the mean fluorescein intensity (  SD) from three inde-
pendently studied mice/group. *P   0.01. (B) BMDCs were treated as
described in A for 48 h. IL-12 levels in culture supernatants were mea-
sured by ELISA. Data represent the averages   SD of IL-12 concentra-
tions in four mice per group. The experiment was repeated five times
with similar results. *P   0.01. 
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from all three strains of DNA-PK KO mice used in this
work strongly suggest that DNA-PK plays no role in medi-
ating the immune response to CpG DNA.
Chu et al. also observed that wortmannin significantly
reduced the immune activation triggered by CpG DNA
and attributed this effect to the inhibition of DNA-PK
function (10). Our results exclude DNA-PK as the wort-
mannin-sensitive mediator of CpG DNA–induced cell
stimulation (Fig. 2). Wortmannin blocks a conserved ATP-
binding site located in the catalytic domain of many mem-
bers of the PI3-kinase family. Class I and III PI3-kinases
facilitate phagocytosis, endocytosis, and endosomal matura-
tion (15–17). Our results suggest that wortmannin-sensitive
PI3-kinases contribute to the internalization and/or trans-
port of CpG ODNs to TLR-9–containing endosomes.
Consistent with such a model, it was recently shown that
PI3-kinases are activated after CpG-mediated stimulation
of DCs (26).
Due to the large number and overlapping activities of
members of the PI3-kinase family, additional studies are
needed to identify the specific kinase(s) that contribute to
CpG-mediated signaling. Indeed, wortmannin sensitivity
does not unequivocally establish that PI3-kinases are in-
volved in this process. However, considerable data (includ-
ing results shown in Figs. 2 and 3) establish that the inhibi-
tory effects of wortmannin are selective for PI3-kinases,
having no impact on responses mediated by other members
of the TLR family.
Taken together, the present findings strongly suggest that
CpG DNA–induced innate immune activation is mediated
through TLR-9 but not DNA-PK and that wortmannin-
sensitive member(s) of the PI3-kinase family play a critical
role in shuttling CpG DNA to TLR-9.
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